Global not-for-profit launches a Data Governance Community of Interest to help companies improve data sharing infrastructure to accelerate R&D innovation
31 March, 2021
Potent antibodies shown to retain binding to major COVID-19-causing “South African” variant. IONTAS is now seeking development partners
26 March, 2021
The Medicines and Healthcare products Regulatory Agency (MHRA) has registered Virolens, which is now the fastest COVID-19 screening device in the country. Instant Covid Tests London’s (ICTL) test centre is based at The Brewery events space in the City of London, neighbouring thousands of workplaces. ICTL offers quick and effective testing solutions, offering businesses and individuals a fast-track back to normality
26 March, 2021
Infex Therapeutics has filed for a UK patent for a novel therapy designed to tackle all coronavirus strains.
26 March, 2021
New service supports UK government test-to-release scheme for day 2 testing. Assay development funded by Innovate UK grant for viral surveillance, received in May 2020
09 March, 2021
Diverse panel of novel target binders from IONTAS / FJB will be used to uncover functional antibodies to advance Quell’s engineered Treg cell therapy pipeline
08 March, 2021
The University of Edinburgh has set an impressive pace in therapeutics commercialisation in recent months with a record number of spinout companies and an enviable roster of industrial collaborations.
08 March, 2021
Evrysdi is the first and only at-home treatment for SMA patients. Opinion based on efficacy results from the FIREFISH and SUNFISH pivotal trials –
04 March, 2021
New survey shows Swedish life science companies even more confident about future growth compared to pre-COVID
03 March, 2021